Shattuck Labs, Inc. - Common Stock — Bilancio Trimestrale (NASDAQ:STTK) | MetaTrader

Apri il grafico completo Full chart

Notizie

Shattuck Labs: Priced As If Risk Was Not A Part Of The Equation (NASDAQ:STTK)

Il CTO di Shattuck Labs Abhinav Shukla vende azioni per $14.244

Il CMO di Shattuck Labs Pandite vende azioni per $198.300

Shattuck Labs: Surviving In An AI World Is Going To Be Tough (NASDAQ:STTK)

TD Cowen conferma rating Buy su Shattuck Labs dopo dati farmaco

Shattuck Labs stock maintained at Buy by TD Cowen on drug data

Piper Sandler avvia copertura su Shattuck Labs con rating Overweight

Piper Sandler initiates Shattuck Labs stock with Overweight rating

Shattuck Labs: "Hold" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot (STTK)

Earnings season to kick off with

Shattuck's Bowel Disease Treatment Looks Promising: Analyst - Shattuck Labs (NASDAQ:STTK)

Shattuck Labs: rating del titolo migliorato a Buy da H.C. Wainwright